Ignite Creation Date:
2024-05-05 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 9:58 AM
Study NCT ID:
NCT00793377
Status:
COMPLETED
Last Update Posted:
2008-11-19
First Post:
2008-11-17
Brief Title:
Neoadjuvant DoxorubicinCyclophosphamide Followed by Docetaxel AC-Doc Versus Dose-Dense Doxorubicin and Docetaxel ADoc in Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group
Organization Data
Organization:
German Breast Group
Class:
OTHER
Study ID:
Gepar-Duo
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
German Breast Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Prof Dr G v Minckwitz
Old Organization:
GBG Forschungs GmbH
Collaborators
| Name | Class |
|---|---|
| German Adjuvant Breast Cancer Group | OTHER |